News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
330 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42568)
2024 (38488)
2025 (26684)
Month
January (4345)
February (4356)
March (4476)
April (4722)
May (4999)
June (4103)
July (3643)
August (3330)
September (4039)
October (5056)
November (4470)
December (3799)
Day
1 (309)
2 (217)
3 (119)
4 (10)
5 (15)
6 (240)
7 (330)
8 (243)
9 (293)
10 (101)
11 (2)
12 (13)
13 (228)
14 (250)
15 (299)
16 (255)
17 (104)
18 (5)
19 (7)
20 (208)
21 (277)
22 (218)
23 (219)
24 (80)
25 (4)
26 (9)
27 (24)
28 (229)
29 (306)
30 (261)
31 (124)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Deals
Dermira Reports First Quarter 2019 Financial Results and Provides Corporate Update
Dermira, Inc. reported financial results for the quarter ended March 31, 2019, provided a corporate update and issued 2019 financial guidance.
May 7, 2019
·
16 min read
Business
Rettsyndrome.org Appoints Joseph Horrigan, MD to Board of Directors
Dr. Horrigan’s appointment follows the excitement of several research and clinical trial advancements supported or developed through Rettsyndrome.org.
May 7, 2019
·
3 min read
Business
Corindus Reports First Quarter 2019 Results
Eleven purchase orders for CorPath GRX Systems as adoption grows
May 7, 2019
·
10 min read
MilliporeSigma Enhances Sustainability with Expanded Green Chemistry Evaluation Tool
To help scientists, researchers and manufacturers reduce their environmental footprint, MilliporeSigma expanded its DOZN™ system — an industry-first quantitative green chemistry tool that evaluates the relative greenness of chemicals and chemical processes against the 12 Principles of Green Chemistry.
May 7, 2019
·
3 min read
Business
Trovagene Announces First Quarter 2019 Results and Highlights
The company is issuing this press release in lieu of conducting a conference call.
May 7, 2019
·
13 min read
Drug Development
WISE enrolls first patient in pivotal clinical study of novel neuro-electrodes for brain monitoring
Milestone reached in development of highly ergonomic and minimally invasive cortical strip electrodes
May 7, 2019
·
5 min read
Business
Electromed, Inc. Announces Fiscal 2019 Third Quarter Financial Results
Net revenue increased 3.4% to $7.4 million from $7.2 million during the three months ended March 31, 2018
May 7, 2019
·
10 min read
Policy
Bernstein Liebhard LLP Announces That Approximately Seven Weeks Remain To Make A Motion For Lead Plaintiff In A Class Against Indivior PLC
The complaint alleges that defendants violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934.
May 7, 2019
·
3 min read
Biotech Bay
HRS 2019: Acutus Medical to Demonstrate Major Advances in Electrophysiology Field
Global Simultaneous Electrical Activation Mapping and Precise Anatomic Chamber Imaging Allow Improved Precision and Effectiveness
May 7, 2019
·
3 min read
Deals
IQVIA Announces Pricing of Offering of Senior Notes
IQVIA Holdings Inc. announced that its wholly-owned subsidiary, IQVIA Inc. (the “Issuer”), priced an offering of $1,100,000,000 in aggregate principal amount of senior notes due 2027
May 7, 2019
·
2 min read
Previous
33 of 33